| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |